Randox is a biotechnology and healthcare startup dedicated to improving global health by pioneering cutting-edge health technologies for early and accurate diagnosis. Established in 1982, Randox operates as an international health diagnostics company with presence in 145 countries. Its product portfolio encompasses Biochip Array Technology, clinical chemistry analyzers and reagents, quality control materials and software, as well as an extensive biosciences portfolio. The company's commitment to leveraging innovative technologies for improved health outcomes positions it as a significant player in the biotechnology and healthcare industries. For more information and a complete product portfolio, interested parties can visit Randox's website at www.randox.com or reach out via email at [email protected].
There is no investment information
No recent news or press coverage available for Randox.